(Q46522353)

English

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine

scientific article published in June 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Haitao Luo

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Lili Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Meng Tang

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Madhavi Billam

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Tianren Huang

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Jiahua Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Zhongliang Wei

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Yongqiang Liang

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Kaibo Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Zhen-Quan Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Lisheng Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Jia-Sheng Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

27

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

262-268

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

International trends and patterns of primary liver cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Multifactoral etiology of human liver cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Antimutagenic and anticarcinogenic activity of tea polyphenols.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Green tea composition, consumption, and polyphenol chemistry

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Cancer chemopreventive activity and bioavailability of tea and tea polyphenols

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Reduced risk of esophageal cancer associated with green tea consumption

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Protective effect of green tea on the risks of chronic gastritis and stomach cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e- and OH adducts

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Oxidative DNA damage and disease: induction, repair and significance

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Longitudinal study of urinary 8-hydroxy-2'-deoxyguanosine excretion in healthy adults

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Tea consumption and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Cancer chemoprevention. A new way to treat cancer before it happens.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Chemopreventive effects of green tea components on hepatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Oxidative DNA damage: mechanisms, mutation, and disease

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

"Action-at-a-distance" mutagenesis. 8-oxo-7, 8-dihydro-2'-deoxyguanosine causes base substitution errors at neighboring template sites when copied by DNA polymerase beta.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Effect of oxidative DNA damage in promoter elements on transcription factor binding

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Oxidative stress in humans: validation of biomarkers of DNA damage

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI147

21 January 2018

Identifiers

10.1093/CARCIN/BGI147

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15930028

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46522353&oldid=2115827989"